nicotinate ribonucleoside has been researched along with vitamin k semiquinone radical in 1 studies
| Studies (nicotinate ribonucleoside) | Trials (nicotinate ribonucleoside) | Recent Studies (post-2010) (nicotinate ribonucleoside) | Studies (vitamin k semiquinone radical) | Trials (vitamin k semiquinone radical) | Recent Studies (post-2010) (vitamin k semiquinone radical) |
|---|---|---|---|---|---|
| 10 | 0 | 5 | 12,827 | 491 | 3,703 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anlezark, GM; Davies, LC; Friedlos, F; Goddard, P; Jarman, M; Knox, RJ; Melton, RG; Sherwood, RF | 1 |
1 other study(ies) available for nicotinate ribonucleoside and vitamin k semiquinone radical
| Article | Year |
|---|---|
Virtual cofactors for an Escherichia coli nitroreductase enzyme: relevance to reductively activated prodrugs in antibody directed enzyme prodrug therapy (ADEPT).
Topics: Animals; Antibodies; Aziridines; Escherichia coli; Mice; NAD; Nitroreductases; Oxidation-Reduction; Prodrugs; Pyridinium Compounds; Ribonucleosides; Vitamin K | 1995 |